Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2003

Nov 26, 2003

29777_dirs_2003-11-26_7206a5d1-c0cf-4817-9f18-faba31dfb702.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2003-11-25

Reporting Person: DE LASA JOSE M (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2003-11-25 Common shares without par value M 3424 $29.19 Acquired 150214 Direct
2003-11-25 Common shares without par value M 2881 $34.70 Acquired 153095 Direct
2003-11-25 Common shares without par value F 4483 $44.58 Disposed 148612 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2003-11-25 Option (right to buy) $29.19 M 3424 Disposed 2007-02-13 Common shares (3424) Direct
2003-11-25 Option (right to buy) $34.70 M 2881 Disposed 2010-02-10 Common shares (2881) Direct
2003-11-25 Option (right to buy) $44.58 A 2241 Acquired 2007-02-13 Common shares (2241) Direct
2003-11-25 Option (right to buy) $44.58 A 2242 Acquired 2010-02-10 Common shares (2242) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 2246 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of November 24, 2003.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.